Directed by N.M.K. Ng Ying Kin, PhD, the laboratory measures putative biological markers for various psychiatric conditions and treatment-resistance to usual medications.

Alain Gratton, PhD, investigates the role of dopamine in drug abuse, as well as exposure to stress.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

The Delusions about Schizophrenia and Psychosis: a 2009 lecture by Ridha Joober - Part 1

Pierre Étienne is a psychiatrist in the geriatric psychiatry program of the Douglas Institute. He is interested in the early development of medication and in Alzheimer's Disease.

The Delusions about Schizophrenia and Psychosis: a 2009 lecture by Ridha Joober - Part 2

Judes Poirier is Person of the week La Presse.

Douglas researchers in Aging and Alzheimer's Disease.

Ridha Joober, MD, PhD, Researcher and Director of the Schizophrenia and Neurodevelopmental Disorders Research at the Douglas Institute, gives an update on schizophrenia during the 2009 Mini-Psych School. He talks about : Genetic factors Environmental factors Who is at risk Neurochemistry of the brain The new neuroleptics Clinical case Part 1 of 2. Watch Part 2 at: http://www.douglas.qc.ca/videos/142?utm_source=YouTube&utm_medium=media%2Bsocial&utm_campaign=Mini-Psy%2B2009-5